SIGA - SIGA Technologies

-

$undefined

N/A

(N/A)

SIGA Technologies NasdaqGM:SIGA SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Location: 31 East 62nd Street, New York, NY, 10065, United States | Website: https://www.siga.com | Industry: Drug Manufacturers - Specialty & Generic | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

266.9M

Cash

162.3M

Avg Qtr Burn

N/A

Short % of Float

10.25%

Insider Ownership

43.25%

Institutional Own.

52.25%

Qtr Updated

03/31/25